Detailed Information on Publication Record
2011
An APEX-based genotyping microarray for the screening of 168 mutations associated with familial hypercholesterolemia
DUŠKOVÁ, Lucie, Lenka KOPEČKOVÁ, Eva JANSOVÁ, Lukáš TICHÝ, Tomáš FREIBERGER et. al.Basic information
Original name
An APEX-based genotyping microarray for the screening of 168 mutations associated with familial hypercholesterolemia
Authors
DUŠKOVÁ, Lucie, Lenka KOPEČKOVÁ, Eva JANSOVÁ, Lukáš TICHÝ, Tomáš FREIBERGER, Petra ZAPLETALOVÁ, Vladimír SOŠKA, Barbora RAVČUKOVÁ and Lenka FAJKUSOVÁ
Edition
Atherosclerosis, Irsko, ELSEVIER SCI IRELAND LTD, 2011, 0021-9150
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
Genetics and molecular biology
Country of publisher
Ireland
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 3.794
Organization unit
Central European Institute of Technology
UT WoS
000290205800022
Keywords in English
Familial hypercholesterolemia; LDLR gene; Microarray; APEX reaction
Tags
International impact, Reviewed
Změněno: 9/3/2017 10:47, Mgr. Lucie Gojová
Abstract
V originále
The aim of this study was, on the basis of data obtained by the molecular genetic analysis of 1945 Czech FH probands, to propose, generate, and validate a new diagnostic tool, an APEX (Arrayed Primer EXtension)-based genotyping DNA microarray called the FH chip.The FH chip contains the APOB mutation p.Arg3527Gln, all 89 LDLR point mutations and small DNA rearrangements detected in Czech FH patients, and 78 mutations frequent in other European and Asian FH populations. This FH chip is a rapid, reproducible, specific, and cost-effective tool for genotyping, and in combination with MLPA (multiple ligation-dependent probe amplification) represents a reliable molecular genetic protocol for the large-scale screening of FH mutations in the Czech population.
Links
MSM0021622415, plan (intention) |
| ||
2B08060, research and development project |
|